BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36695557)

  • 41. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
    Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
    Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results.
    Van Hoovels L; Vander Cruyssen B; Sieghart D; Bonroy C; Nagy E; Pullerits R; Čučnik S; Dahle C; Heijnen I; Bernasconi L; Benkhadra F; Bogaert L; Van Den Bremt S; Van Liedekerke A; Vanheule G; Robbrecht J; Studholme L; Wirth C; Müller R; Kyburz D; Sjöwall C; Kastbom A; Ješe R; Jovancevic B; Kiss E; Jacques P; Aletaha D; Steiner G; Verschueren P; Bossuyt X
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35321875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort.
    Murata K; Ito H; Hashimoto M; Murakami K; Watanabe R; Tanaka M; Yamamoto W; Matsuda S
    Arthritis Res Ther; 2020 Nov; 22(1):268. PubMed ID: 33183344
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.
    Roos Ljungberg K; Joshua V; Skogh T; Eklund A; Sköld CM; Karimi R; Nyrén S; Svärd A; Catrina AI; Kastbom A
    Rheumatology (Oxford); 2020 Apr; 59(4):852-859. PubMed ID: 31504962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.
    Sherina N; Hreggvidsdottir HS; Bengtsson C; Hansson M; Israelsson L; Alfredsson L; Lundberg K
    Arthritis Res Ther; 2017 Sep; 19(1):219. PubMed ID: 28962582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.
    Mjaavatten MD; van der Heijde DM; Uhlig T; Haugen AJ; Nygaard H; Bjørneboe O; Kvien TK
    J Rheumatol; 2011 Nov; 38(11):2336-41. PubMed ID: 21965645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis.
    Roos Ljungberg K; Börjesson E; Martinsson K; Wetterö J; Kastbom A; Svärd A
    Arthritis Res Ther; 2020 Nov; 22(1):274. PubMed ID: 33225988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
    Roos Ljungberg K; Martinsson K; Wetterö J; Svärd A; Kastbom A
    Clin Exp Immunol; 2021 Jun; 204(3):344-351. PubMed ID: 33675063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
    Goules JD; Goules AV; Tzioufas AG
    Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
    Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
    Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benefits of anticitrullinated peptides examination in rheumatoid arthritis.
    Belakova G; Manka V; Zanova E; Racay P
    Niger J Clin Pract; 2018 Oct; 21(10):1380-1383. PubMed ID: 30297575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthood.
    Combier A; Frantz C; Wipff J; Bazeli R; Elhai M; Feydy A; Quartier P; Touanga Ngoti G; Thomas M; Deslandre C; Avouac J; Allanore Y
    Joint Bone Spine; 2023 Mar; 90(2):105501. PubMed ID: 36574572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis.
    Hughes-Austin JM; Gan RW; Deane KD; Weisman MH; Demoruelle MK; Sokolove J; Robinson WH; Holers VM; Norris JM; Ix JH
    Am J Nephrol; 2017; 46(6):481-487. PubMed ID: 29237149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rheumatoid Meningitis: A Case Review.
    Parsons AM; Zuniga LA; Hoxworth JM; Lyons M; Aslam F; Goodman BP
    Neurologist; 2018 May; 23(3):83-85. PubMed ID: 29722740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased IgA anti-citrullinated protein antibodies in the periodontal inflammatory exudate of healthy individuals compared to rheumatoid arthritis patients.
    Rahajoe PS; de Smit M; Schuurmans G; Raveling-Eelsing E; Kertia N; Vissink A; Westra J
    J Clin Periodontol; 2020 May; 47(5):552-560. PubMed ID: 32141631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study.
    Mrabet D; Laadhar L; Sahli H; Zouari B; Haouet S; Lahmar H; Makni S; Sellami S
    Clin Rheumatol; 2012 Feb; 31(2):375-9. PubMed ID: 21952975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis.
    Trier NH; Holm BE; Heiden J; Slot O; Locht H; Jensen B; Lindegaard H; Svendsen A; Nielsen CT; Jacobsen S; Theander E; Houen G
    J Immunol Methods; 2018 Mar; 454():6-14. PubMed ID: 29128424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seroprevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Rheumatic Diseases other than Rheumatoid Arthritis.
    Saigal R; Bhakal SS; Goyal L; Goel AD
    J Assoc Physicians India; 2018 Apr; 66(4):26-8. PubMed ID: 30347947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.
    Huang J; Zeng T; Zhang X; Tian Y; Wu Y; Yu J; Pei Z; Liu Y; Hu T; Tan L
    Br J Biomed Sci; 2020 Jan; 77(1):19-23. PubMed ID: 31433746
    [No Abstract]   [Full Text] [Related]  

  • 60. Extra-articular involvement of rheumatoid arthritis in three seropositive patients in the absence of initial joint involvement.
    Chirila RM; Berianu F; Abril A; Butendieck RR
    Immun Inflamm Dis; 2021 Dec; 9(4):1613-1617. PubMed ID: 34473908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.